[1] Ahn H J, Han K D, Choi E K, et al. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study[J]. Cardiovascular diabetology, 2021, 20: 1-13.
[2] Chew N W S, Ng C H, Tan D J H, et al. The global burden of metabolic disease: Data from 2000 to 2019[J]. Cell Metabolism, 2023, 35(3): 414-428. e3.
[3] Wang F, Glenn A J, Tessier A J, et al. Integration of epidemiological and blood biomarker analysis links haem iron intake to increased type 2 diabetes risk[J]. Nature Metabolism, 2024, 6(9): 1807-1818.
[4] 刘娅, 韩新年. 天然补铁剂—血红素铁的研究进展[J].中国食品添加剂, 2005, 4:4.
[5] Trudel X, Brisson C, Gilbert-Ouimet M, et al. Long working hours and the prevalence of masked and sustained hypertension[J]. Hypertension, 2020, 75(2): 532-538.
[6] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压病学分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志(中英文),2024,32(07):603-700.
[7] Jensen T, Abdelmalek M F, Sullivan S, et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease[J]. Journal of hepatology, 2018, 68(5): 1063-1075.
[8] Guo X, Zheng L, Wang J, et al. Epidemiological evidence for the link between sleep duration and high blood pressure: a systematic review and meta-analysis[J]. Sleep medicine, 2013, 14(4): 324-332.
[9] 丁露，肖新华. 吸烟与糖尿病[J]. 中华糖尿病杂志，2020，12(09):736-739
[10] Li Y, Liu Y, Liu S, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies[J]. Signal Transduct Target Ther, 2023, 8(1):152.
[11] Escobar E. Hypertension and coronary heart disease[J]. J Hum Hypertens, 2002, 16 Suppl 1:S61-3.
[12] Mennuni S, Rubattu S, Pierelli G, et al. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage[J]. J Hum Hypertens, 2014, 28(2):74-9.
[13] 田露, 薛浩. 肥胖与心血管疾病的研究进展[J].中华全科医师杂志, 2024, 23:(03)：305-308.
[14] 王战建, 王伟. 肥胖相关性肾病[J]. 国际泌尿系统杂志, 2009, 29:(02)：268-270.
